Meet Rodney Turner, CEO of Multiplex Protein Analysis Company AYOXXA
BIO-Europe offers many opportunities. One of them is meeting with companies’ representatives to have a chat. In this context, we met with Rodney Turner, CEO of German company AYOXXA, which markets a technology for multiplex protein analysis.
Although it may sound complicated, the technology is quite straightforward. Simply put, it is the parallel analysis of multiple proteins from one single, very small sample.
Made for academics and researchers studying a variety of sample types – blood, serum, eye fluids, saliva, or cerebrospinal fluids – AYOXXA’s LUNARIS™ technology provides the opportunity to observe how the level of all signal proteins changes in response to a drug.
It also helps to understand how the immune system works and how inflammation develops in response to infections or other diseases.